The DOI matches its Crossref record.
Pravastatin-loaded chitosan nanoparticles: Formulation, characterization and cytotoxicity studies
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“determined by the indirect method (Badran et al., 2016).”
From The use of chitosan-coated flexible liposomes as a remarkable carrier to enhance the antitumor efficacy of 5-fluorouracil against colorectal cancer (2019) · cites this paper as Badran et al., 2016
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 43
- Abdel Mouez, 2014, Bioavailability enhancement of verapamil HCl via intranasal chitosan microspheres, Eur. J. Pharm. Sci., 51, 59, 10.1016/j.ejps.2013.08.029 · DOI
- Abdel-Hamid, 2012, ultra performance liquid chromatography determination of pravastatin sodium in erythrocytes, Asian J. Chem., 24, 584
- Anitha, 2014, Chitin and chitosan in selected biomedical applications, Prog. Polym. Sci., 39, 1644, 10.1016/j.progpolymsci.2014.02.008 · DOI
- Azadi, 2013, Methotrexate-loaded chitosan nanogels as 'Trojan Horses' for drug delivery to brain: preparation and in vitro/in vivo characterization, Int. J. Biol. Macromol., 62, 523, 10.1016/j.ijbiomac.2013.10.004 · DOI
- Bahreini, 2014, Preparation and nanoencapsulation of l-asparaginase II in chitosan-tripolyphosphate nanoparticles and in vitro release study, Nanoscale Res. Lett., 9, 340, 10.1186/1556-276X-9-340 · DOI
- Bhattarai, 2010, Chitosan-based hydrogels for controlled, localized drug delivery, Adv. Drug Deliv. Rev., 62, 83, 10.1016/j.addr.2009.07.019 · DOI
- Coimbra, 2010, Liposomal pravastatin inhibits tumor growth by targeting cancer-related inflammation, J. Control. Release, 148, 303, 10.1016/j.jconrel.2010.09.011 · DOI
- Dash, 2010, Kinetic modeling on drug release from controlled drug delivery systems, Acta Pol. Pharm., 67, 217
- Deepa, 2014, Versatile carboxymethyl chitin and chitosan nanomaterials: a review, WIREs Nanomed. Nanobiotechnol., 6, 574, 10.1002/wnan.1301 · DOI
- Ding, 2011, Facile preparation of a cationic poly(amino acid) vesicle for potential drug and gene co-delivery, Nanotechnology, 22, 1, 10.1088/0957-4484/22/49/494012 · DOI
- Dong, 2013, Scalable ionic gelation synthesis of chitosan nanoparticles for drug delivery in static mixers, Carbohydr. Polym., 94, 940, 10.1016/j.carbpol.2013.02.013 · DOI
- Fan, 2012, Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique, Coll. Surf. B Biointerfaces, 90, 21, 10.1016/j.colsurfb.2011.09.042 · DOI
- Fröhlich, 2012, The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles, Int. J. Nanomed., 7, 5577, 10.2147/IJN.S36111 · DOI
- Ghori, 2014, Simultaneous quantification of drug release and erosion from hypromellose hydrophilic matrices, Int. J. Pharm., 465, 405, 10.1016/j.ijpharm.2014.02.028 · DOI
- Graf, 2008, Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma, Digestion, 78, 34, 10.1159/000156702 · DOI
- Hamidi, 2008, Hydrogel Nanoparticles Drug Deliv., 60, 1638
- Hamidi, 2010, Encapsulation of valproate-loaded hydrogel nanoparticles in intact human erythrocytes: a novel nano-cell composite for drug delivery, J. Pharm. Sci., 100, 1702, 10.1002/jps.22395 · DOI
- Harisa, 2016, Pravastatin chitosan nanogels-loaded erythrocytes as a new delivery strategy for targeting liver cancer, Saudi Pharm. J., 24, 74, 10.1016/j.jsps.2015.03.024 · DOI
- Huading, 2013, Porous chitosan scaffolds with embedded Hyaluronic acid/chitosan/plasmid-DNA nanoparticles encoding TGF-β1 induce DNA controlled release, transfected chondrocytes, and promoted cell proliferation, PLoS One, 8, e69950, 10.1371/journal.pone.0069950 · DOI
- Katz, 2005, Therapy insight: potential of statins for cancer chemoprevention and therapy, Nat. Clin. Pract. Oncol., 2, 82, 10.1038/ncponc0097 · DOI
- Kawata, 2001, Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomised controlled trial, Br. J. Cancer, 84, 886, 10.1054/bjoc.2000.1716 · DOI
- Kivisto, 2007, Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans, Pharm. Res., 24, 239, 10.1007/s11095-006-9159-2 · DOI
- Lee, 2004, Physicochemical properties and blood compatibility of acylated chitosan nanoparticles, Carbohydr. Polym., 58, 371, 10.1016/j.carbpol.2004.06.033 · DOI
- Lee, 2011, Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations, J. Natl. Cancer Inst., 103, 674, 10.1093/jnci/djr070 · DOI · Paper page
- Lifeng, 2006, In vivo antitumor activity of chitosan nanoparticles, Bioorg. Med. Chem. Lett., 16, 4243, 10.1016/j.bmcl.2006.05.078 · DOI
- Benito-Miguel, 2015, Assessment of sequential combination of 5-fluorouracil-loaded-chitosan-nanoparticles and ALA-photodynamic therapy on HeLa cell line, Photodiagnosis Photodyn. Ther., 12, 466, 10.1016/j.pdpdt.2015.05.001 · DOI
- Menter, 2011, Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites, PLoS One, 6, e28813, 10.1371/journal.pone.0028813 · DOI
- Mohammed, 2013, Natural bioadhesive biodegradable nanoparticles-based topical ophthalmic formulations for sustained celecoxib release: in vitro study, J. Pharm. Technol. Drug Res.
- Montori, 2014, Patient-centered and practical application of new high cholesterol guidelines to prevent cardiovascular disease, J. Am. Med. Assoc., 311, 465, 10.1001/jama.2014.110 · DOI
- Prabaharan, 2015, Chitosan-based nanoparticles for tumor-targeted drug delivery, Int. J. Biol. Macromol., 72C, 1313, 10.1016/j.ijbiomac.2014.10.052 · DOI
- Prabhu, 2015, Polymeric nanoparticles for targeted treatment in oncology: current insights, Int. J. Nanomed., 5, 161
- Ramezani, 2009, The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes, Coll. Surf. B Biointerfaces, 72, 1, 10.1016/j.colsurfb.2009.03.018 · DOI
- Riekes, 2011, Evaluation of oral carvedilol microparticles prepared by simple emulsion technique using poly (3-hydroxybutyrate-co-3- hydroxyvalerate) and polycaprolactone as polymers, Mater. Sci. Eng. C, 31, 962, 10.1016/j.msec.2011.02.017 · DOI
- Smith, 2012, Anticancer activity of the cholesterol exporter ABCA1 gene, Cell Rep., 27, 580, 10.1016/j.celrep.2012.08.011 · DOI
- Sultana, 2013, Nanoparticles-mediated drug delivery approaches for cancer targeting: a review, J. Drug Target., 21, 107, 10.3109/1061186X.2012.712130 · DOI
- Trapani, 2011, Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery, Int. J. Pharm., 419, 296, 10.1016/j.ijpharm.2011.07.036 · DOI · Paper page
- Tummala, 2015, Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer, Saudi Pharm. J., 23, 308, 10.1016/j.jsps.2014.11.010 · DOI
- Wilson, 2010, Chitosan nanoparticlesasa new delivery system for the anti-Alzheimer drug tacrine, Nanomed. Nanotechnol. Biol. Med., 6, 144, 10.1016/j.nano.2009.04.001 · DOI
- Wong, 2002, HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis, Leukemia, 16, 508, 10.1038/sj.leu.2402476 · DOI
- Xia, 2011, Biological activities of chitosan and chitooligosaccharides, Food Hydrocoll., 25, 170, 10.1016/j.foodhyd.2010.03.003 · DOI
- Yokoi, 2014, Serum biomarkers for personalization of nanotherapeutics-based therapy in different tumor and organ microenvironments, Cancer Lett., 345, 48, 10.1016/j.canlet.2013.11.015 · DOI
- Zaki, 2012, Enhanced antibacterial effect of ceftriaxone sodium-loaded chitosan nanoparticles against intracellular Salmonella typhimurium, AAPS Pharm. Sci. Tech., 13, 411, 10.1208/s12249-012-9758-7 · DOI
- Zhou, 2007, Preparation, characterization and anticancer effect of chitosan nanoparticles, J. Clin. Rehabil. Tissue Eng. Res., 11, 9688
Cited by
Sorted by citations
Alomrani, A., Badran, M., Harisa, G. I., ALshehry, M., Alhariri, M., Alshamsan, A., & Alkholief, M. (2019) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2019.02.008 · Cited by 143
Self-citationApplication of nanotechnology to improve the therapeutic benefits of statins
Korani, S., Korani, M., Bahrami, S., Johnston, T. P., Butler, A. E., Banach, M., & Sahebkar, A. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.09.023 · Cited by 51
An overview on nanoplatforms for statins delivery: Perspectives for safe and effective therapy
Etemad, L., Salmasi, Z., Moosavian Kalat, S. A., Moshiri, M., Zamanian, J., Kesharwani, P., & Sahebkar, A. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116572 · Cited by 18
Metadata
- Authors
- Badran, M. M., Harisa, G. I., AlQahtani, S. A., Alanazi, F. K., & Zoheir, K. M. A.
- ORCID
- Badran, Mohamed M.
- Venue
- Journal of Drug Delivery Science and Technology
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 32
- Pages
- 1-9
- ISSN
- 1773-2247
- Cited by
- 33
- References
- 0
- Language
- en
- Funders
- King Saud University (G-2015-1)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pravastatin-loaded chitosan nanoparticles: Formulation, characterization and cytotoxicity studies. https://app.cochat.ai/papers/10.1016/j.jddst.2016.01.004
- The paper
- Badran, M. M., Harisa, G. I., AlQahtani, S. A., Alanazi, F. K., & Zoheir, K. M. A. (2016). Pravastatin-loaded chitosan nanoparticles: Formulation, characterization and cytotoxicity studies. Journal of Drug Delivery Science and Technology. https://doi.org/10.1016/j.jddst.2016.01.004